Author: admin

  • Addressing Psychosocial Barriers Key During Soft Tissue Sarcoma Surgery Recovery

    Addressing Psychosocial Barriers Key During Soft Tissue Sarcoma Surgery Recovery

    A new study from McGill University is shedding light on how patients with soft tissue sarcoma, a rare cancer affecting connective tissues, perceive their health and quality of life (QOL) 1 year after surgery.

    The findings, published in the Journal of Surgical Oncology, underscore that returning to normal life extends far beyond physical recovery, with social engagement, meaningful activity, and emotional well-being emerging as critical factors. As survivorship grows, wrote the researchers, integrating whole-person care, from functional restoration to emotional resilience, will be key to helping patients with sarcoma truly reclaim their lives.

    Soft tissue sarcoma primarily strikes adults in their working years and is typically treated with radiation therapy followed by wide surgical resection. While this approach improves survival, it can cause lasting impairments, such as tissue damage, wound complications, and mobility limitations. Until now, most studies assessing patient outcomes have focused narrowly on physical function using the Toronto Extremity Salvage Score (TESS), a widely used assessment tool for patients following surgery for musculoskeletal tumors.2 However, researchers say this measure misses key dimensions of recovery.

    To capture a more complete picture, the McGill team used 2 patient-reported outcome measures (PROMs) on 276 patients: the Reintegration to Normal Living Index (RNLI), which assesses perceived health and social reintegration, and the EuroQol-5D-3L (EQ-5D), which measures health-related QOL (HRQOL) across mobility, pain, and emotional well-being.

    The researchers applied the Wilson-Cleary Model, a framework linking biological symptoms, functional status, health perceptions, and overall QOL, to evaluate how these factors interact.

    Both tools showed strong reliability (RNLI α = .91; EQ-5D α = .74) and excellent model fit, validating their use in this population. Notably, pain and participation in daily activities were major drivers of perceived health and HRQOL, explaining over half of the variance in patient well-being.

    At 12 months post-surgery, many patients still struggled with recreational activities, family roles, and travel, factors that had a greater impact on QOL than physical limitations alone.

    “In other words, it was not the physical restrictions themselves (e.g., being unable to walk very far), but the implications of the restrictions that seemed most bothersome,” explained the researchers. Nearly half (49%) reported moderate-to-severe anxiety or depression, despite access to psychosocial support services, compared to just 12% in the general population.

    These findings, wrote the researchers, highlight the need for holistic rehabilitation, incorporating occupational therapy to help patients adapt activities and mental health care to address distress that may impede recovery.

    The authors recommend three key strategies for improving long-term outcomes, including maximizing functional restoration through tailored rehabilitation programs, encouraging participation in fulfilling activities, even in modified forms, and implementing routine distress screening to identify patients struggling with anxiety or depression.

    “Moreover, given the systemic restraints many physicians face, occupational therapists and mental health professionals may need to play a more active role in routine soft tissue sarcoma care,” wrote the researchers. “Occupational therapists can help identify hindrances in functional restoration, make pragmatic environmental adjustments, and introduce adaptive equipment.”

    Given that health perceptions explained 52% of HRQOL variance, addressing psychosocial barriers is as essential as physical therapy, noted the group. The study also validated the Wilson-Cleary Model as a robust framework for understanding patient recovery and guiding care.

    The research team acknowledges limitations, including potential underreporting of pain and reliance on the older EQ-5D-3L measure. Still, the results underscore a pressing message: recovery from sarcoma is not just physical; it’s deeply social and psychological.

    References

    1. Andersen NJ, Bergeron C, Turcotte R, Körner A. Health perceptions and HRQL with soft-tissue sarcoma at 12 months post-op: using the Wilson-Cleary model to evaluate the measurement properties of the RNLI and EQ-5D-3L. J Surg Oncol. Published online September 14, 2025. doi:10.1002/jso.70101

    2. Clayer M, Doyle S, Sangha N, Grimer R. The Toronto Extremity Salvage Score in unoperated controls: an age, gender, and country comparison. Sarcoma. 2012;2012:717213. doi:10.1155/2012/717213

    Continue Reading

  • Egypt qualify for FIFA World Cup 2026 with win over Djibouti | Football News

    Egypt qualify for FIFA World Cup 2026 with win over Djibouti | Football News

    Two goals from Salah and one from Adel make Egypt the third African country after Morocco and Tunisia to book a berth.

    Egypt have booked a berth at the FIFA World Cup…

    Continue Reading

  • Get in the Halloween Spirit with General Mills

    Get in the Halloween Spirit with General Mills

    This year, General Mills has an incredible lineup of new and returning Halloween-ready goodies that are perfect for every ghostly gathering. Whether you’re looking to fill trick-or-treat bags with exciting surprises, pack festive lunchboxes for school or simply want to add some frightening flair to your family celebrations, our Halloween line-up is designed to bring the boo! We’ve got frightfully fun new snacks making their debut, alongside beloved returning favorites that fans look forward to every year.

    Make sure to add these must-have items to your shopping list and get ready to impress all the little monsters and goblins who come knocking at your door — or simply treat yourself to the spirit of the season!

    Trick-or-Treating Fun

    Continue Reading

  • Fed Divided Over More Interest Rate Cuts, Minutes Show

    Fed Divided Over More Interest Rate Cuts, Minutes Show

    Topline

    While a majority of the Federal Reserve’s policymaking panel voted last month to lower interest rates, officials disputed how many additional cuts could come this year, with “around half” favoring two more easements by December, according to minutes from the panel’s meeting released Wednesday.

    Key Facts

    “Almost all” of the Fed’s Federal Open Market Committee expected a 25-basis-point cut to interest rates in September, while the “vast majority” projected two cuts by the end of the year, and “around half” expected three.

    The FOMC, which includes 19 officials who participate in policy meetings, 12 of whom vote, expressed a “range of views” about “the degree to which the current stance of monetary policy was restrictive,” and “most judged that it likely would be appropriate to ease policy further over the remainder of the year,” according to the minutes.

    A “dot plot” marking individual expectations from Fed officials indicated a 10-9 split, with the majority expecting two more quarter-point rate cuts by its last meeting in December, potentially lowering rates to between 3.5% and 3.75%.

    Projections from the Fed suggest at least one interest rate cut each in 2026 and 2027, bringing the range to between 3% and 3.25%.

    The FOMC will meet for two days starting Oct. 28, with a decision on interest rates announced the following day, before its final meeting this year on Dec. 9.

    What Else Did The Fed Say?

    A “majority” of participants at the FOMC meeting emphasized “upside risks” to inflation and noted that, while risks to the job market had risen, an uptick in unemployment and a “sharp deterioration” in labor market conditions were unlikely. Officials said they would continue to weigh the risks to both inflation and employment while considering how to adjust monetary policy.

    What To Watch For

    Fed Chair Jerome Powell, who said last month the central bank shifted its concerns from stubborn inflation to a weakening job market, will speak Thursday at 8:30 a.m. EDT to open a bank conference in Washington, D.C. Fed governors Michelle Bowman and Michael Barr are also scheduled to speak.

    Key Background

    The Fed voted 11-1 in September for a quarter-point interest rate cut—the first cut since December. Fed Governor Stephen Miran, appointed to the role by President Donald Trump just before the central bank’s meeting, was the lone vote against the quarter-point reduction, instead arguing in favor of a half-point cut. Trump has pressured Powell and the Fed to cut interest rates by as much as 2%, repeatedly calling Powell “TOO LATE.” Fed officials have shown a willingness to lower interest rates at least twice this year, though Powell has upheld a cautious approach to policy as unemployment rises and inflation remains well above the Fed’s 2% goal. Fed governors Philip Jefferson and Bowman have raised concerns about the weakening labor market as a reason to lower interest rates, as Bowman argued a “shock could tip it into a sudden and significant deterioration.”

    Further Reading

    ForbesFed’s Powell Cites Weakening Job Market For Interest Rate Cut

    Continue Reading

  • Just a moment…

    Just a moment…

    Continue Reading

  • Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation – Regeneron

    1. Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation  Regeneron
    2. FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC  The American Journal of Managed Care® (AJMC®)
    3. FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma Treatment  CUREtoday.com
    4. Regeneron stock rises after FDA approves Libtayo for high-risk skin cancer  Investing.com
    5. FDA Approves Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma  Oncology Nursing News

    Continue Reading

  • Saudi Shura Council delegation in Pakistan to boost parliamentary cooperation

    Saudi Shura Council delegation in Pakistan to boost parliamentary cooperation

    Afghan music collector fears for cassette legacy as Pakistan intensifies deportations


    PESHAWAR: A faint Pashto melody drifts through the dense alleyways of Board Bazaar in the…

    Continue Reading

  • Save 33% on this Anker portable laptop charger at Amazon today

    Save 33% on this Anker portable laptop charger at Amazon today


    Shop this last-chance Amazon deal on a top-rated laptop charger before Prime Big Deal Days ends tonight.

    Just about everyone keeps a power bank for their phone and while they’re a great gadget to have on busy work days, game days and even when

    Continue Reading

  • Logitech’s MX Master 3S is one of the best wireless mice around, and it’s 25 percent off

    Logitech’s MX Master 3S is one of the best wireless mice around, and it’s 25 percent off

    While it lacks the haptics of the newer MX Master 4, Logitech’s MX Master 3S is nearly as good in several ways. It has quiet clicks, horizontal and vertical scroll wheels that are fun to spin, and a comfortable grip. And, for a limited time,…

    Continue Reading

  • This Startup Wants to Spark a US DeepSeek Moment

    This Startup Wants to Spark a US DeepSeek Moment

    Ever since DeepSeek burst onto the scene in January, momentum has grown around open source Chinese artificial intelligence models. Some researchers are pushing for an even more open approach to building AI that allows model-making to be…

    Continue Reading